Get started
Author

Mai Morimoto

Observed names: M. Morimoto, Mai MORIMOTO
ORCID: 0009-0005-3703-5922
Observed ORCID: 0009-0005-3703-5922
OpenAlex ID: A5078278491
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
2008 · Y. Kondo, T. Yoshimoto, et al. · International Immunology · 494
Thu0106 Systemic Immune-inflammation Index in Rheumatoid Arthritis Patients: Relation to Disease Activity
2019 · Takahiro Yoshikawa, Tetsuya Furukawa, et al. · Annals of the Rheumatic Diseases · 7
PDF
A retrospective analysis of 7 cases of familial mediterranean fever
2017 · Chie OGITA, Kiyoshi MATSUI, et al. · Japanese Journal of Clinical Immunology · 5
PDF
A case of refractory otitis media with high-titer positive serum MPO-ANCA value
2010 · Naoto AZUMA, Chieri KANDA, et al. · Japanese Journal of Clinical Immunology · 5
PDF
Marked efficacy of metronidazole for the intestinal pseudoobstruction associated with systemic sclerosis
2011 · Naoto AZUMA, Aki NISHIOKA, et al. · Japanese Journal of Clinical Immunology · 3
PDF
IgG4-related Kidney Disease in Which the Urinalysis, Kidney Function and Imaging Findings Were Normal
2015 · Miho Otani, Masahiro Morinaga, et al. · Internal Medicine · 2
PDF
Tuberculous peritonitis during etanercept therapy for rheumatoid arthritis
2011 · Naoto AZUMA, Mai MORIMOTO, et al. · Japanese Journal of Clinical Immunology · 2
PDF
AB0162 Shared decision making between patient and rheumatologist using a novel touch-panel system for treating rheumatoid arthritis to target
2013 · A. Kunii, N. Yokogawa, et al. · Annals of the Rheumatic Diseases · 1
Cutaneous necrotizing vasculitis in a patient with Behcet's disease; mimicking polyarteritis nodosa
2010 · Naoto AZUMA, Masaru NATSUAKI, et al. · Japanese Journal of Clinical Immunology · 1
PDF
Ozoralizumab, a trivalent anti-TNFα NANOBODY® compound, is resistant to rheumatoid factor-mediated modulation of FcRn-dependent recycling and immune complex uptake
2026 · Mai Morimoto, Yukihisa Sawa, et al. · Frontiers in Immunology
PDF
Oral health-related quality of life in Sjögren’s disease patients with unstimulated whole salivary flows ≥0.1 ml/min for whom no therapeutic approaches are provided in the EULAR recommendations
2025 · Naoto Azuma, Maki Iwatani, et al. · Modern Rheumatology
Pos1251 Oral Health-related Quality of Life in Sjögren’s Syndrome Patients With Unstimulated Whole Salivary Flows ≥0.1 Ml/min for Whom No Therapeutic Approaches Are Provided in the Eular Recommendations
2024 · N. Azuma, M. Iwatani, et al. · Annals of the Rheumatic Diseases
Positivity in serum MMP-3 after clinical remission or low disease activity at 52 weeks leads to future joint destruction in patients with rheumatoid arthritis
2024 · Hiroe Konishi, Mai Morimoto, et al. · medRxiv
PDF
Ab0311 Increased Levels of Serum Wisteria Floribunda Agglutininpositive Mac-2 Binding Protein in Rheumatic Diseases Including Sle
2021 · T. Yoshikawa, K. Azuma, et al. · Annals of the Rheumatic Diseases
PDF
Fri0113 the Baseline Soluble Gp130 Is Associated With the Response of Rheumatoid Arthritis Patients to Sarilumab
2020 · T. Yoshikawa, T. Furukawa, et al. · Annals of the Rheumatic Diseases
PDF
AB0811 Increased levels of serum wisteria floribunda agglutinin-positive mac-2 binding protein in systemic sclerosis
2018 · Y. Yokoyama, T. Yoshikawa, et al. · Annals of the Rheumatic Diseases
PDF
AB0557 Effects of tocilizumab on bone homeostasis and DICKKOPF-1 in rheumatoid arthritis
2012 · M. Kitano, S. Kitano, et al. · Annals of the Rheumatic Diseases
Works count: 17
Citation count: 520
H-index: 4
I10-index: 1
Year
Topic
Type